Z-0601-2019 Class III Terminated
FDA device recall Z-0601-2019 was initiated by Tosoh Bioscience Inc on Oct 5, 2018 and is designated Class III. Reason for recall: Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and… The recall status is terminated (terminated Jun 16, 2020). Affected quantity: 1000.
Recall details
- Product Type
- Devices
- Report Date
- Dec 19, 2018
- Initiation Date
- Oct 5, 2018
- Termination Date
- Jun 16, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1000
Product description
Reason for recall
Distribution pattern
Distributed nationwide. Foreign distribution to Canada.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0601-2019
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.